Healthcare


 Mesoblast Limited Slips Post Releasing Phase 2 Trial Result

Mesoblast Limited Slips Post Releasing Phase 2 Trial Result

November 12, 2018 07:35 AM AEDT| By Team Kalkine Media

Mesoblast Limited (ASX:MSB) presented the results of the phase 2 trial from the test conducted on 159 patients, on November 12, 2018. The end results from the test conducted by the implantation of the left ventricular assist device on the heart failu...

 Healthscope Opens With A Gap-Up After Receiving A Proposal From Brookfield

Healthscope Opens With A Gap-Up After Receiving A Proposal From Brookfield

November 12, 2018 04:45 AM AEDT| By Team Kalkine Media

Healthscope Limited (ASX: HSO) received a ?Takeover Offer? from Brookfield Capital Partners Ltd, as announced on November 12, 2018. Brookfield Capital Partners Ltd along with its affiliate partners and managed funds presented a proposal to have 100%...

 Proteomics International Laboratories Advances On Key Performance Results Of PromarkerD Kit

Proteomics International Laboratories Advances On Key Performance Results Of PromarkerD Kit

November 09, 2018 11:58 AM AEDT| By Team Kalkine Media

Proteomics International Laboratories Limited (ASX: PIQ) came up with performance results of PromarkerD immunoassay kit. The results were presented on November 9, 2018 at the 18th Annual Diabetes Technology meeting held between November 08, and Novem...

 Nanosonics Slightly Bounces Back After The AGM

Nanosonics Slightly Bounces Back After The AGM

November 09, 2018 04:33 AM AEDT| By Team Kalkine Media

Nanosonics Limited (ASX: NAN) had its Annual General Meeting on November 9, 2018, i.e. today. Strengthening its position internationally, NAN has delivered an outstanding series of milestones virtually across all dimensions of the business. Company i...

 Suda Pharmaceuticals Is All Set To Commercialize SUD-001H

Suda Pharmaceuticals Is All Set To Commercialize SUD-001H

November 08, 2018 08:43 AM AEDT| By Team Kalkine Media

Suda Pharmaceuticals Limited (ASX:SUD) announced regarding its entry into an?exclusive product development, licence and supply agreement with the fully owned subsidiary of Strides Pharma Science Ltd, Strides Pharma Global Pte Ltd on November 8, 2018....

 ResMed Slips After Acquisition Update

ResMed Slips After Acquisition Update

November 06, 2018 08:40 AM AEDT| By Team Kalkine Media

ResMed Inc (ASX:RMD) has issued a press release on November 6, 2018, announcing its entry into an agreement and plan of merger of ResMed operations Inc, a Delaware corporation and a wholly owned subsidiary of ResMed Operations MatrixCare Holdings, In...

 Why Is This Medical Company Soaring On ASX - Reva Medical?

Why Is This Medical Company Soaring On ASX - Reva Medical?

November 06, 2018 07:30 AM AEDT| By Team Kalkine Media

REVA Medical, Inc. (ASX: RVA) is a leader in bioresorbable polymer technologies for vascular medical applications; and despite the increasing challenges in the European BS market, substantial growth in the product shipments and new customers acquisit...

 Cellmid - Anti-Baldness Company – Disappointed With Outcome As It Loses Court Case

Cellmid - Anti-Baldness Company – Disappointed With Outcome As It Loses Court Case

November 06, 2018 03:56 AM AEDT| By Team Kalkine Media

Cellmid, the anti-baldness company loses court case against its former marketing agency which has forced the company to spend nearly $1 million. Cellmid (ASX: CDY) is developing cancer and heart disease treatments and makes hair growth tonics. Its ha...

 Clinuvel Pharmaceuticals Shares Uplifted By 8.6 Percent After The Release Of Company’s Newsletter

Clinuvel Pharmaceuticals Shares Uplifted By 8.6 Percent After The Release Of Company’s Newsletter

November 05, 2018 01:10 PM AEDT| By Team Kalkine Media

In the recently released quarterly results, Clinuvel Pharmaceuticals Limited (ASX: CUV) confirmed the steady growth in clinical demand for SCENESSE? in erythropoietic protoporphyria (EPP) which is a rare genetic metabolic disorder. The Cash receipts...

 Clover Makes Investment In Melody Dairies: What Investors Need To Know

Clover Makes Investment In Melody Dairies: What Investors Need To Know

November 05, 2018 05:59 AM AEDT| By Team Kalkine Media

On November 5, 2018, Clover Corporation Limited (ASX: CLV) came forward and made an announcement that it has made an acquisition of 35% stake in Melody Dairies which is situated in Waikato Innovation Park in Hamilton, New Zealand. This marks the comp...

 Cann Group Limited Betting On The Development Of First Big Glass Roof Factory

Cann Group Limited Betting On The Development Of First Big Glass Roof Factory

November 05, 2018 05:46 AM AEDT| By Team Kalkine Media

Cann Group Limited (ASX: CAN) with its strong long term objective to be the Australian industry leader and? to develop sufficient capacity to serve expanding export markets and with its ?continuous focus on the development of the medicinal cannabis a...

 Cochlear Limited’s Shares Plunged On Unfavorable Outcome Of Ruling In USA Patent Infringement Case

Cochlear Limited’s Shares Plunged On Unfavorable Outcome Of Ruling In USA Patent Infringement Case

November 05, 2018 02:28 AM AEDT| By Team Kalkine Media

On 5 November 2018, Cochlear Limited (ASX: COH) announced that the United States District Court in Los Angeles has ruled against the company in the patent infringement lawsuit by the Alfred E. Mann Foundation for Scientific Research (AMF) and Advance...

 Healthscope Trading At Low Levels With Growing Investor-Driven Pressure

Healthscope Trading At Low Levels With Growing Investor-Driven Pressure

November 02, 2018 07:08 AM AEDT| By Team Kalkine Media

Healthscope Limited (ASX:HSO) is facing tough pressure from its investors. Joining the list of Healthscope shareholders, DNR capital has also raised questions to the chairman Paula Dwyer, regarding the disclosure of the company's books to a private e...

 Living Cell Technologies’ Shares Trading In Green Zone After The Release Of Trial Results From Phase IIb Study Of NTCELL

Living Cell Technologies’ Shares Trading In Green Zone After The Release Of Trial Results From Phase IIb Study Of NTCELL

November 02, 2018 05:21 AM AEDT| By Team Kalkine Media

Living Cell Technologies Limited (ASX: LCT) has presented the trial results from the Phase IIb study of NTCELL for Parkinson's disease. The trial commenced in March month of year 2016. The lead product of LCT, which is NTCELL is a capsule coated with...

 One Pot Stock That Soared Up After Securing Potential Manufacture Licence – Althea!

One Pot Stock That Soared Up After Securing Potential Manufacture Licence – Althea!

November 02, 2018 02:37 AM AEDT| By Team Kalkine Media

Althea Group Holdings Limited?s (ASX:AGH) wholly owned subsidiary Althea Company Pty Ltd has secured the manufacture licence from the Australian Government?s Office of Drug Control on November 02, i.e., today. Including this licence, Althea now holds...

 RACE Oncology Limited Is On Upswing After The Appointment Of Biosynergy

RACE Oncology Limited Is On Upswing After The Appointment Of Biosynergy

November 01, 2018 07:36 AM AEDT| By Team Kalkine Media

RACE Oncology Limited (ASX:RAC) has executed the service agreement with New York based Biosynergy partners LLC, in order to pursue licensing of Bisantrene and other deals for the agreement. The Biosynergy partners is owned by one of the previous dire...

 Why Is Japara Healthcare Edging Up On ASX?

Why Is Japara Healthcare Edging Up On ASX?

November 01, 2018 04:03 AM AEDT| By Team Kalkine Media

Up 1.78% on November 01, 2018 (1:50 PM AEST), Japara HealthCare Limited (ASX:JHC) had its annual general meeting organized as on October 31, 2018, addressing all its shareholders. Management provided a brief review on FY18 operations and management?s...

 Nib Soars As Management Uplifted FY19 Earning Guidance

Nib Soars As Management Uplifted FY19 Earning Guidance

October 31, 2018 08:49 AM AEDT| By Team Kalkine Media

Health insurer Nib Holdings surged up 6.334% on uplifted earnings guidance for Fiscal 2019. After going up by $0.330, nib?s stock price closed at $5.540 on the day of its Annual General Meeting, 31 October 2018. Early this morning nib unveiled its u...

 Biotron Slips After Its Reply To ASX

Biotron Slips After Its Reply To ASX

October 31, 2018 08:31 AM AEDT| By Team Kalkine Media

Biotron Limited (ASX:BIT) has shown a huge growth potential this year. Current market capitalization of Biotron stands at $90.32 mn as on October 31, 2018 i.e., today. Grown from a market cap of $10 mn to the current market cap of $90.32 mn shows the...

 Healthscope Edges Up On AGM Address

Healthscope Edges Up On AGM Address

October 31, 2018 07:07 AM AEDT| By Team Kalkine Media

Healthscope Ltd (ASX:HSO) had its annual general meeting organized as on October 31, 2018. Financial health check-up along with FY19 guidance were presented in this AGM. 3.7% rise in the group revenue up to $ 2.3 billion was posted in FY18 as compar...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.